Product Information
METHIMAZOLE 5 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.0722 per EA under NDC 64380021201. Its NADAC has been published 213 times since Jun 1, 2022.
The Low Outlier badge above means this manufacturer's average price in the methimazole market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380021201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METHIMAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA040350On Market Since
3/14/2022
Pharmacological Classes
Price Statistics
The NADAC for METHIMAZOLE 5 MG TABLET has been published 213 times since Jun 1, 2022, and over the history we have for it it has risen 19.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0722 per EA |
|---|---|
| All-time high | $0.1140 (Sep 13, 2023) |
| All-time low | $0.0602 (Jun 1, 2022) |
| 52-week high | $0.0864 |
| 52-week low | $0.0718 |
| Median price | $0.0761 |
| Average price | $0.0787 |
| Largest weekly change | +27.3% (Aug 23, 2023) |
| Weeks tracked | 213 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METHIMAZOLE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHIMAZOLE 5 MG TABLET, manufactured by Strides Pharma Inc., is $0.0722 per EA (NDC 64380021201), effective Jun 24, 2026.
How has the price of METHIMAZOLE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHIMAZOLE 5 MG TABLET has risen 19.9%. It has been tracked across 213 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for METHIMAZOLE 5 MG TABLET?
Since Jun 1, 2022, the NADAC for METHIMAZOLE 5 MG TABLET has ranged from a low of $0.0602 (Jun 1, 2022) to a high of $0.1140 (Sep 13, 2023), with a median of $0.0761 per EA.
Are there cheaper alternatives to METHIMAZOLE 5 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as METHIMAZOLE 5 MG TABLET, but none are currently priced below it.
Who manufactures METHIMAZOLE 5 MG TABLET?
METHIMAZOLE 5 MG TABLET (NDC 64380021201) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification